Search Results - "HAUSNER, P"

Radiation Dose Versus Activity as a Prognostic Factor in Metastatic Colorectal Cancer Patients Who Received Selective Internal Radiation Therapy to the Liver Using Yttrium-90 Resin Microspheres by Chuong, M.D, Bhooshan, N, Sharma, N, Moeslein, F, Horiba, N, Alexander, H, Hausner, P, Regine, W, Kudryasheva, S, Yi, B

Get full text

Radiographic Tumor Volume Change as a Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer Patients Who Received Selective Internal Radiation Therapy to the Liver Using Yttrium-90 Resin Microspheres by Chuong, M.D, Bhooshan, N, Moeslein, F, Horiba, N, Hanna, N, Alexander, H, Hausner, P, Regine, W, Kudryasheva, S, Sharma, N

Get full text

Pretreatment Tumor Volume as a Prognostic Factor in Metastatic Colorectal Cancer Patients Who Received Selective Internal Radiation Therapy to the Liver Using Yttrium-90-Coated Resin Microspheres by Bhooshan, N, Sharma, N, Moeslein, F, Horiba, M, Hausner, P, Hanna, N, Alexander, H, Regine, W, Amin, P, Kudryasheva, S, Chuong, M.D

Get full text

Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference by Hassan, R, Alexander, R, Antman, K, Boffetta, P, Churg, A, Coit, D, Hausner, P, Kennedy, R, Kindler, H, Metintas, M, Mutti, L, Onda, M, Pass, H, Premkumar, A, Roggli, V, Sterman, D, Sugarbaker, P, Taub, R, Verschraegen, C

“…Peritoneal mesothelioma is a rare cancer of the peritoneum with about 250 new cases diagnosed each year in the United States. It is the second most common site…”
Get full text

The Impact of Prophylactic Cranial Irradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Trimodality Therapy by Patel, A.B, Edelman, M.J, Burrows, W, Hausner, P, Kwok, Y, Krasna, M, Suntharalingam, M

Get full text

The Effect of Radiation Therapy on Malignant Fistulae of Anorectal Cancers by Koroulakis, A., Sullivan, M., Molitoris, J.K., Jiang, Y., Hausner, P., Miller, R.C., Regine, W.F.

Get full text

The allosteric three-site model for the ribosomal elongation cycle. New insights into the inhibition mechanisms of aminoglycosides, thiostrepton, and viomycin by Hausner, T P, Geigenmüller, U, Nierhaus, K H

“…According to the allosteric three-site model for the ribosomal elongation cycle (Rheinberger, H.J. and Nierhaus, K.H. (1986) J. Biol. Chem. 261, 9133-9139),…”
Get full text

Pulmonary Resection After Curative Intent Radiotherapy (>59 Gy) and Concurrent Chemotherapy in Non–Small-Cell Lung Cancer by Sonett, Joshua R., Suntharalingam, Mohan, Edelman, Martin J., Patel, Ashish B., Gamliel, Ziv, Doyle, Austin, Hausner, Peter, Krasna, Mark

“…Pulmonary resection after chemotherapy and concurrent full-dose radiotherapy (>59 Gy) has previously been associated with unacceptably high morbidity and…”
Get full text

Generation of immunoglobulin/c-myc recombinations in murine Peyer's patch follicles by Müller, J R, Mushinski, E B, Jones, G M, Williams, J A, Janz, S, Hausner, P F, Potter, M

Get more information

The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors by Suntharalingam, M, Sonett, J R, Haas, M L, Doyle, L A, Hausner, P F, Schuetz, J, Krasna, M J

“…Patients presenting with apical sulcus tumors have historically been treated with preoperative radiotherapy followed by surgical resection. Since 1991, we have…”
Get more information

Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma by Suntharalingam, M, Haas, M L, Sonett, J R, Doyle, L A, Hausner, P F, Schuetz, J, Greenwald, B, Krasna, M J

“…The diagnosis of esophageal carcinoma has historically been associated with a poor prognosis. Recently, investigators have reported improved outcomes for this…”
Get more information

Treatment of melanoma with wild-type p53 (wtp53) and detectable S100B using pentamidine: A phase II trial with correlative biomarker endpoints by Mehnert, J. M., Hausner, P. F., Tan, M., Weber, D., Sausville, E. A.

“…Abstract only…”
Get full text

High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival by Kwong, King F., Edelman, Martin J., Suntharalingam, Mohan, Cooper, Lindsay B., Gamliel, Ziv, Burrows, Whitney, Hausner, Petr, Doyle, L. Austin, Krasna, Mark J.

“…We sought to study the clinical characteristics and outcomes of patients treated with a surgery-inclusive multimodality approach for Pancoast tumors. Clinical…”
Get full text

The Thy-1 glycoprotein is expressed in mouse embryonal carcinoma cells P19 by Dráber, P, Malý, P, Hausner, P, Pokorná, Z

“…Thy-1 is a well characterized glycoprotein known to be variably expressed on the surface of different cell types. Serological analysis of a limited number of…”
Get full text

Immunoglobulin/Myc recombinations in Murine Peyer's patch follicles by Müller, Jürgen R., Mushinski, Elizabeth B., Williams, Joy A., Hausner, Petr F.

“…Immunoglobulin heavy chain (Igh)/Myc recombinations are a hallmark of pristane‐induced mouse plasmacytomas but are also frequently found in non‐tumorous…”
Get full text

Phase 2 study of cryptophycin 52 ( LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer by Edelman, Martin J, Gandara, David R, Hausner, Petr, Israel, Valerie, Thornton, Donald, DeSanto, Jennifer, Doyle, L.Austin

“…Background: Cryptophycin 52 is a novel antitubulin drug with in vitro and in vivo activity in non-small cell lung cancer. Based upon promising Phase 1 data, a…”
Get full text

Phase I study of docetaxel and topotecan in patients with solid tumors by TKACZUK, Katherine H, ZAMBONI, William C, TAIT, Nancy S, MEISENBERG, Barry R, DOYLE, L. Austin, EDELMAN, Martin J, HAUSNER, Petr F, EGORIN, Merrill J, VAN ECHO, David A

“…Both docetaxel (DOC), a promoter and stabilizer of microtubule assembly, and topotecan (TOPO), a topoisomerase I inhibitor, have shown antitumor activity in a…”
Get full text

Phase II Trial of the Novel Retinoid, Bexarotene, and Gemcitabine Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer by EDELMAN, Martin J, SMITH, Ruth, HAUSNER, Petr, DOYLE, L. Austin, KALRA, Kavita, KENDALL, Joyce, BEDOR, Michelle, BISACCIA, Sonia

“…Platinum-based chemotherapy is the standard treatment for advanced non-small-cell lung cancer (NSCLC). Unfortunately, a plateau in efficacy with currently…”
Get full text

Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia by Klener, P, Háber, J, Hausner, P

“…In four patients treated for progressive B-CLL, stage C, with alpha-2b interferon a detailed analysis of the distribution of surface molecules characterizing…”
Get full text

Phase II trial of gemcitabine/carboplatin (GC) followed by paclitaxel (P) in patients with performance status = 2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer (NSCLC) by Bridges, B. B., Thomas, L., Hausner, P., Doyle, L. A., Bedor, M., Smith, R., Brahmer, J., Edelman, M. J.

“…Abstract only 7661 Introduction: The role of chemotherapy (Rx) in patients (pts) with advanced NSCLC and poor performance status (PPS) defined as PS = 2 or 3…”
Get full text